Scientists scan brains to see how new depression drug works
NCT ID NCT07329621
Summary
This early-stage study aims to understand how an experimental medication called MSP-2020 attaches to specific targets in the brain. Researchers will use brain scans and blood tests in 18 healthy male volunteers to measure how the drug interacts with brain receptors and how long it stays in the body. The main goal is to gather basic information about the drug's behavior and safety before testing it in people with depression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INCOMPLETE RESPONSE - MAJOR DEPRESSIVE DISORDER (IR-MDD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
HMR Hammersmith Medicines Research Ltd.
RECRUITINGLondon, United Kingdom
Conditions
Explore the condition pages connected to this study.